Emgality on AARP Medicare Rx Preferred from UHC (S5921-387)
galcanezumab
Covered, with prior authorization required.
Tier 3 (preferred brand). Quantity limit of 2 per 28 days.
$263.34
Patient pays / month, after deductible
$371.24
Patient pays / month, before the $130.00 deductible
$790.02
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
EMGALITY 120 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,549.06 for a month. Other covered strengths are listed below.
Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| EMGALITY 120 mg/mL Injection, Solution | 3 | $263.34 | PA · 2 per 28 days |
| EMGALITY 120 mg/mL Injection, Solution | 3 | $263.85 | PA · 2 per 28 days |
| EMGALITY 100 mg/mL Injection, Solution | 4 | $656.42 | PA · 3 per 28 days |
Other CGRP migraine drugs on this plan
Verify with the plan before prescribing or filling. Member services: (866)870-3470. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5921-387